Seed VC · UK

Epidarex

Active

What they invest in

A transatlantic venture capital firm building breakthrough life science companies in emerging hubs by identifying transformative investments in under-ventured regions of the US and UK through deep scientific and industry networks.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers

Geography

US, UK

Recent investments

  • AdoRx Therapeutics
  • Apellis Pharmaceuticals
  • Caldan Therapeutics

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

10 partners on file at Epidarex, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Epidarex writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Epidarex alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United Kingdom
Last known deal
Mar 2019
Portfolio last checked
Oct 6, 2026
Website
www.epidarex.com ↗

Other firms investing in DeepTech

See all investors

Is Epidarex the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Epidarex is one of them, and we'll tell you exactly where they sit in your top 100.